• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, October 25, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Exploring Ketogenic Diet and Lacosamide in Epilepsy Treatment

Bioengineer by Bioengineer
October 3, 2025
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In a groundbreaking study published in BMC Pediatrics, researchers led by Pang et al. investigate the therapeutic potentials of a ketogenic diet, combined pharmacological therapies, and the individual efficacy of lacosamide in treating children with refractory epilepsy. This research highlights the increasing relevance of dietary interventions alongside traditional medication in managing epilepsy, which is often challenging to control, particularly in pediatric populations. With the complexity of epilepsy disorders, this study delves into the need for alternative and complementary therapeutic approaches to improve the quality of life for affected children.

The ketogenic diet, known for its high-fat, low-carbohydrate content, has gained recognition for its potential to reduce seizure frequency. Historically, the ketogenic diet was initially developed in the 1920s to treat epilepsy. Recent scholarly attention surrounding dietary management has shifted focus back to this method, particularly for patients resistant to conventional treatments. The present study aims to dissect the effectiveness of the ketogenic diet juxtaposed with lacosamide therapy, providing a closer look at the biochemical mechanisms involved.

Lacosamide is a medication that stabilizes neuronal membranes and inhibits repetitive neuronal firing, making it a logical candidate in the arsenal against seizures. Its unique mechanism of action differentiates it from other antiepileptic drugs and may provide enhanced seizure control when used alongside dietary therapies. This study formulates a comprehensive analysis of how combining lacosamide with a tailored ketogenic diet can synergistically enhance therapeutic outcomes for children struggling with epilepsy.

Throughout the research, data was gathered from multiple sites, contributing to a robust and diversified pool of subjects ranging in age and seizure types. The methodology included strict adherence to dietary protocols and standardized dosing of lacosamide, ensuring a controlled environment for accurate measurements of efficacy. Patients in the study were monitored closely over several months, with regular assessments of seizure frequency, severity,

Tags: alternative therapies for epilepsybiochemical mechanisms of epilepsy treatmentcomplementary approaches in epilepsy caredietary interventions in epilepsy treatmenteffectiveness of ketogenic diethigh-fat low-carbohydrate diet benefitsketogenic diet for epilepsylacosamide in pediatric epilepsypediatric epilepsy treatment optionspharmacological therapies for seizuresrefractory epilepsy managementseizure frequency reduction strategies

Tags: dietary interventions in neurologyketogenic diet for epilepsylacosamide therapypediatric epilepsy treatmentrefractory epilepsy management
Share12Tweet8Share2ShareShareShare2

Related Posts

Glycation Boosts Alpha-Synuclein Aggregation, Neuroinflammation

October 25, 2025

Glycation Boosts Alpha-Synuclein Aggregation, Neuroinflammation

October 25, 2025

Utilizing Mutual Gaze to Enhance Social Skills in Autism

October 25, 2025

Glymphatic Flow Dysfunction Linked to Parkinson’s Disease

October 25, 2025

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1281 shares
    Share 512 Tweet 320
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    309 shares
    Share 124 Tweet 77
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    192 shares
    Share 77 Tweet 48
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    133 shares
    Share 53 Tweet 33

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Glycation Boosts Alpha-Synuclein Aggregation, Neuroinflammation

Glycation Boosts Alpha-Synuclein Aggregation, Neuroinflammation

Utilizing Mutual Gaze to Enhance Social Skills in Autism

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 67 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.